$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Analysis of the efficacy and safety of ensidipine in the treatment of AML
2026-02-01 22:25:32
Check Details
Ensidipine combined with venetoclax is a new combination therapy with high remission rate in the treatment of AML
2026-02-01 22:25:32
Check Details
Explore treatment options beyond ensidipine
2026-02-01 22:25:32
Check Details
A complete guide to purchasing the Lao version of crizotinib generic drug
2026-02-01 22:25:32
Check Details
What are the taboos while taking ivonib?
2026-02-01 22:25:32
Check Details
Average resistance time to ivonib
2026-02-01 22:25:32
Check Details
How long should I take ivonib for?
2026-02-01 22:25:32
Check Details
How much does a box of ruxolitinib ointment cost?
2026-02-01 22:25:32
Check Details
Is ruxolitinib ointment available in China?
2026-02-01 22:25:32
Check Details
How much will ruxolitinib ointment cost in 2024?
2026-02-01 22:25:32
Check Details
Is ruxolitinib ointment included in medical insurance when it is launched in China?
2026-02-01 22:25:32
Check Details
What does ruxolitinib ointment do?
2026-02-01 22:25:32
Check Details
1
2
...
979
980
981
982
983
984
985
...
10224
10225
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Mitotane Side Effects: Understanding Key Risks in Adrenocortical Carcinoma Therapy
2
Ponatinib: A Third-Generation TKI Targeting BCR::ABL1 to Overcome Leukemia Drug Resistance
3
Axitinib: Indications, Mechanism of Action & Key Safety Warnings
4
Cabergoline Explained: Mechanism, Four Key Warnings & Dosing Guide
5
Capmatinib Generic Guide: Laos Version Availability, Efficacy & Safety Overview
6
Eltrombopag Administration Timing and Alternative Therapy Guide
7
Osimertinib Safety Guide: Foods to Avoid, Mechanism of Action, and Pre-Treatment Warnings
8
Avatrombopag: A Complete Guide to Dosage, Mechanism, and Clinical Use
9
Tazemetostat Dosage Guide: Laos Generic vs. Original Tazverik Comparison
10
Tivozanib: A Next-Generation Highly Selective VEGFR-Targeted Therapy Explained
11
Capmatinib Clinical Guide: Drug Comparisons, Treatment Strategies, and Combination Therapy Prospects
12
Avatrombopag Complete Guide: Efficacy, Indications, and TPO-RA Drug Comparisons